Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Anti-fake battery pack and identification system thereof
System and method for converting biomass to ethanol via syngas
Content display system
Alterable account number
Towel clip
System and method for optimizing teams
Particles with high surface charge for crystalline colloidal arrays
  Randomly Featured Patents
Car lamp
Dynamic seal for well tools
Golf club
Paint bucket liner
sCD40L and placental growth factor (PLGF) used as a biochemical marker combination in cardiovascular diseases
Recording/reproducing system
Lift mechanism for one or more developer members in an image forming device
Method and apparatus for detecting unintentional islanding of utility grid
Device for eliminating electromagnetic waves
System and method for testing of electronic circuits